Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Irritable Bowel Syndrome

Free Subscription 12.09.2022 2 Aliment Pharmacol Ther 1 Am J Lifestyle Med 1 BMC Womens Health 1 Chin Med J (Engl) 1 Clin Nutr 2 Curr Opin Pharmacol 1 Eur J Health Econ 1 Front Cell Neurosci 1 Front Pharmacol 1 Front Physiol 1 Indian J Gastroenterol 1 J Biol Chem 1 J Parasitol Res 1 Parasit Vectors 1 Phys Med 1 Singapore Med J

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
   Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply.
   Aliment Pharmacol Ther. 2022;56:1217-1218.
   PubMed        
   
   
2. GU Y, Xiang Y
   Letter: efficacy of peppermint oil in irritable bowel syndrome.
   Aliment Pharmacol Ther. 2022;56:1215-1216.
   PubMed        
   
   

   
   Am J Lifestyle Med

3. THOMAS A, Thomas A, Butler-Sanchez M
   Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome.
   Am J Lifestyle Med. 2021;16:608-621.
   PubMed         Abstract available
   
   

   
   BMC Womens Health

4. DE LAS MERCEDES VILLA ROSERO C, Mazin SC, Nogueira AA, Vargas-Costales JA, et al
   Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador.
   BMC Womens Health. 2022;22:363.
   PubMed         Abstract available
   
   

   
   Chin Med J (Engl)

5. LIU Z, Zhu S, He M, Li M, et al
   Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity.
   Chin Med J (Engl). 2022 Aug 25. pii: 00029330-990000000-00145.
   PubMed         Abstract available
   
   

   
   Clin Nutr

6. CHU N, Chan JC, Chow E
   A diet high in FODMAPs as a novel dietary strategy in diabetes?
   Clin Nutr. 2022;41:2103-2112.
   PubMed         Abstract available
   
   

   
   Curr Opin Pharmacol

7. ALGERA JP, Tornblom H, Simren M
   Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome.
   Curr Opin Pharmacol. 2022;66:102284.
   PubMed         Abstract available
   
   
8. HUSSEIN H, Boeckxstaens GE
   Immune-mediated food reactions in irritable bowel syndrome.
   Curr Opin Pharmacol. 2022;66:102285.
   PubMed         Abstract available
   
   

   
   Eur J Health Econ

9. MANIPIS K, Mulhern B, Haywood P, Viney R, et al
   Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment.
   Eur J Health Econ. 2022 Sep 8. pii: 10.1007/s10198-022-01512.
   PubMed         Abstract available
   
   

   
   Front Cell Neurosci

10. ZHAN TT, Dong ZY, Yi LS, Zhang Y, et al
    Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats.
    Front Cell Neurosci. 2022;16:922750.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

11. BAO W, Qi L, Bao Y, Wang S, et al
    Alleviating insomnia should decrease the risk of irritable bowel syndrome: Evidence from Mendelian randomization.
    Front Pharmacol. 2022;13:900788.
    PubMed         Abstract available
    
    

    
    Front Physiol

12. YANG H, Hou C, Xiao W, Qiu Y, et al
    The role of mechanosensitive ion channels in the gastrointestinal tract.
    Front Physiol. 2022;13:904203.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

13. GORKA AM, Nauta F, Bijlsma MW, Taselaar P, et al
    Current treatment practice of functional abdominal pain disorders in children: A multicenter survey.
    Indian J Gastroenterol. 2022 Sep 3. pii: 10.1007/s12664-022-01253.
    PubMed         Abstract available
    
    

    
    J Biol Chem

14. XI M, Zhao P, Li F, Bao H, et al
    MicroRNA-16 inhibits the TLR4/NF-kappaB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea.
    J Biol Chem. 2022 Sep 3:102461. doi: 10.1016/j.jbc.2022.102461.
    PubMed         Abstract available
    
    

    
    J Parasitol Res

15. ROSHIDI N, Arifin N
    Disease Biomarkers of Giardiasis.
    J Parasitol Res. 2022;2022:1932518.
    PubMed         Abstract available
    
    

    
    Parasit Vectors

16. FRANKLIN F, Rajamanikam A, Raju CS, Gill JS, et al
    Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.
    Parasit Vectors. 2022;15:313.
    PubMed         Abstract available
    
    

    
    Phys Med

17. HUBBARD CRISTINACCE PL, Keaveney S, Aboagye EO, Hall MG, et al
    Clinical translation of quantitative magnetic resonance imaging biomarkers - An overview and gap analysis of current practice.
    Phys Med. 2022;101:165-182.
    PubMed         Abstract available
    
    

    
    Singapore Med J

18. TAN ZE, Tan YQ, Lin H, How CH, et al
    Irritable bowel syndrome: an approach for primary care physicians.
    Singapore Med J. 2022;63:367-370.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: